Resumen
Obesity is a chronic disease with a significant and growing impact on Canadians. The “Awareness, Care and Treatment In Obesity MaNagement” (ACTION) Study investigated perceptions, attitudes and perceived barriers to obesity management among Canadian people with obesity (PwO), healthcare providers (HCPs) and employers. In this study adult PwO (body mass index ≥30 kg/m2, based on self-reported height/weight), HCPs (physicians and allied HCPs managing PwO) and employers (≥20 employees; offering health insurance), completed online surveys between 3 August and 11 October 2017 in a cross-sectional design. Survey respondents (N = 2545) included 2000 PwO, 395 HCPs and 150 employers. Obesity was viewed as a “chronic medical condition” by most PwO (60%), HCPs (94%) and employers (71%) and deemed to have a large impact on overall health (74%, 78%, 81%, respectively). Many PwO (74%) believed weight management was their own responsibility. While PwO (55%) reportedly knew how to manage their weight, only 10% reported maintaining ≥10% weight reduction for >1 year. Despite low success rates, the most commonly reported effective long-term weight loss methods tried and/or recommended were “improvements in eating habits” (PwO 38%; HCP 63%) and “being more active” (PwO 39%; HCP 54%). PwO and HCPs reported very different perceptions of the quality and content of their interaction during obesity management discussions. These findings highlight the communication gaps and misunderstanding between PwO, HCPs and employers. This underscores the importance of, and need for, evidence-based management of obesity and a collaborative approach and understanding of the complex nature of this chronic disease.
Idioma original | English |
---|---|
Número de artículo | e12329 |
Publicación | Clinical obesity |
Volumen | 9 |
N.º | 5 |
DOI | |
Estado | Published - oct. 1 2019 |
Nota bibliográfica
Funding Information:information Novo NordiskThe study was sponsored by Novo Nordisk A/S. All authors contributed substantially to the design and/or analysis of the article and the interpretation of data; drafted the article or revised it critically for important intellectual content; gave final approval of the version to be published; and agreed to act as guarantor of the work (ensuring that questions related to any part of the work are appropriately investigated and resolved). The authors are grateful to Geula Bernstein, PhD, John Howell PhD and Emma Kenny, PhD (of AXON Communications; supported by Novo Nordisk) for writing assistance; and to David Scowcroft and Mario Elizondo (supported by Novo Nordisk) for data analyses.
Publisher Copyright:
© 2019 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation
ASJC Scopus Subject Areas
- Endocrinology, Diabetes and Metabolism